Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy

Area of Science:

• Neuroscience
• Hepatology
• Biochemistry

Background:

• Hepatic encephalopathy (HE) is a complex neurological complication of liver cirrhosis.
• Current theories suggest HE involves altered cerebral catecholamine metabolism, specifically decreased dopamine and noradrenaline, and increased octopamine.

Purpose of the Study:

• To investigate brain tissue levels of dopamine, noradrenaline, and octopamine in patients with cirrhosis and HE.
• To determine if catecholamine disturbances underlie HE in human liver cirrhosis.

Main Methods:

• Analysis of brain tissue (locus niger, caudate nucleus, hypothalamus, thalamus, frontal cortex) from 34 individuals (22 cirrhotic patients with/without HE, 12 controls).
• Tissue samples were obtained post-mortem (necropsy) and during neurosurgical procedures.

Main Results:

• Dopamine and noradrenaline levels were consistent across cirrhotic patients (with or without HE) and controls (P < 0.05).
• Octopamine levels were found to be lower in cirrhotic patients with HE compared to control subjects.

Conclusions:

• The study contradicts animal findings, showing no decline in dopamine or noradrenaline in the brains of cirrhotic patients with HE.
• Elevated octopamine levels are not characteristic of HE in human liver cirrhosis.
• Cerebral catecholamine disturbance is unlikely to be the primary cause of hepatic encephalopathy in human liver cirrhosis.